Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 20.72M | $ 1.79M | $ 0 | -8.63% |
3/31/2025 | $ 66.4M | $ 145K | $ 0 | -0.22% |
12/31/2024 | $ 71.4M | $ 29.25M | $ 0 | -40.97% |
9/30/2024 | $ 197.68M | $ 29.32M | $ 0 | -14.83% |
6/30/2024 | $ 279.32M | $ 29.92M | $ 0 | -10.71% |
3/31/2024 | $ 317.53M | $ 29.92M | $ 0 | -9.42% |
12/31/2023 | $ 422.92M | $ 880K | $ 0 | -0.21% |
9/30/2023 | $ 128.13M | $ 2.21M | $ 0 | -1.72% |
6/30/2023 | $ 192.63M | $ 3.06M | $ 0 | -1.59% |
3/31/2023 | $ 227.47M | $ 13.03M | $ 0 | -5.73% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: (-1 * CF - Equity [ $ 339.93M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 823.52M ]
(=) Payout Yield [ -41.28% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |